Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by jojomarch

V.TLT

RE:Comparing Ph. 1b data: Photofrin vs TLD-1433

The doctors throw the net with the TLD 1433 compound and then light it up...

December 6, 2019

V.TLT

RE:Comparing Ph. 1b data: Photofrin vs TLD-1433

The doctors throw the net with the TLD 1433 compound  and then light it...

December 6, 2019

V.QNC

RE:RE:RE:Qrng—-relevancy and application confirmed

FarmerInvestor4 wrote: AbNormAl wrote: I note FarmerInvestor4 keeps...

December 6, 2019

V.TLT

RE:RE:Merck, Novartis, Medtronic Cash on Hand

LaserStock29 wrote: Bump, just to continue on about that royality deal...

December 6, 2019

V.QNC

RE:Qrng—-relevancy and application confirmed

Sextant wrote: Bertrand’s invention should make for excitement once applied...

December 6, 2019

V.QNC

RE:Gentlemen can disagree.

AbNormAl wrote: IR would have cost QNC a pile over the past three years. PM...

December 5, 2019

V.TLT

RE:RE:RE:Bladder Cancer Treatment Enters 'Post-Checkpoint' Era

SAGE developping an  " uncertainty "  drug  is down&...

December 5, 2019

V.TLT

RE:RE:Bladder Cancer Treatment Enters 'Post-Checkpoint' Era

Claridge wrote: Choosing Post-Immunotherapy Milowsky noted that if these...

December 5, 2019

V.TLT

RE:Similar much.... time to tweet @ Bio Optics World

LaserStock29 wrote: Photodynamic therapy Iridium Oct 17/2019 A team of...

December 4, 2019

V.TLT

RE:RE:Fig. 3 - Keytruda's Time to CR and time to recurences

If our treated patients are CR after 7 days they will be CR at 90 and 180 IMO...

December 4, 2019

V.QNC

RE:RE:RE:BMO

With the westerly winds the VSE has done its part in spreading manure in our...

December 3, 2019

V.TLT

RE:RE:PH1b

Claridge wrote: Jojomarch ... If Rutherrin requires shelf certification, than...

December 3, 2019

V.TLT

PH1b

Management has told us that the next indication PH1b will start when the PH2&...

December 3, 2019

V.QNC

BMO

Like most of us here  , there is an investor buying through BMO that...

December 2, 2019

V.TLT

RE:RE:RE:RE:Company future value

IMO a lot of those immunotherapy companies with their lofty valuations will...

December 2, 2019

V.TLT

RE:RE:RE:RE:Clinical Hold

Time for P5 and P6 to go on a book tour . Go on national radio , go on TV...

November 30, 2019

V.TLT

Approval

I suspect when TLT announce the FDA IND approval they will combine it with...

November 29, 2019

V.TLT

RE:Collecting data @30 and 60 days ... ;-)

Claridge wrote: One important difference between Ph. 1b and Ph. 2b ... They...

November 28, 2019

V.TLT

RE:RE:RE:RE:RE:New TLD-1433 & TOOKAD Article in ScienceDirect June 2020

Thanks Eoganacht . It would be nice to know the math behind this transaction...

November 27, 2019

V.TLT

RE:RE:New TLD-1433 & TOOKAD Article in ScienceDirect June 2020

Conflict of interest statement Theralase licenses the exclusive worldwide...

November 27, 2019

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Pulsar Helium Inc.

Pulsar Helium Inc. V.PLSR

Pulsar Helium Inc. is a Canada-based helium exploration and development company. The Company's assets include the flagship ... view more »